Alfresa Holdings Corporation Stock
Stocks
2784
JP3126340003
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Japan Exchange
09:30:00 28/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 2,415.00 JPY | -1.75% |
|
+2.85% | -0.66% |
| 10-05 | Healios Completes First 144 Million Yen Culture Supernatant Shipment to JENECEL | MT |
| 07-01 | Ember LifeSciences, Inc. announced that it has received funding from Alfresa Holdings Corporation | CI |
| Market Cap | 424B 2.68B 2.4B 2.22B 2.01B 3.76B 255B 3.8B 26.55B 10.58B 133B 10.05B 9.84B | P/E 2027 * |
18.2x | P/E 2028 * | 15.4x |
|---|---|---|---|---|---|
| Enterprise Value | 424B 2.68B 2.4B 2.22B 2.01B 3.76B 255B 3.8B 26.55B 10.58B 133B 10.05B 9.84B | EV / Sales 2027 * |
0.13x | EV / Sales 2028 * | 0.13x |
| Free-Float |
88.98% | Yield 2027 * |
2.94% | Yield 2028 * | 3.3% |
| Markets | Quality | ||
|---|---|---|---|
Japan Exchange
| 2784 | Delayed | |
OTC Markets
| ARHCF | Delayed |
| 1 day | -1.75% | ||
| 1 week | +2.85% | ||
| Current month | +6.11% | ||
| 1 month | +1.15% | ||
| 3 months | +0.25% | ||
| 6 months | +1.58% | ||
| Current year | -0.66% |
| 1 week | 2,349 |  | 2,497 |
| 1 month | 2,210 | | 2,497 |
| Current year | 2,106.5 | | 2,685.5 |
| 1 year | 2,106.5 | | 2,685.5 |
| 3 years | 1,897 | | 2,685.5 |
| 5 years | 1,505 | | 2,685.5 |
| 10 years | 1,505 | | 3,350 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ryuji Arakawa
CEO | Chief Executive Officer | 63 | - |
Watase Maiko
ADM | Chief Administrative Officer | - | - |
Toshiki Tanaka
CTO | Chief Tech/Sci/R&D Officer | 63 | 28/06/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Ryuji Arakawa
BRD | Director/Board Member | 63 | 01/06/2007 |
Yuji Ueda
BRD | Director/Board Member | 65 | 25/06/2025 |
Yusuke Fukujin
BRD | Director/Board Member | 50 | 01/06/2020 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.75% | +2.85% | +8.98% | +1.32% | 2.73B | |
| -0.45% | +2.12% | -18.93% | +10.37% | 178B | |
| +0.86% | +2.15% | -19.13% | +15.77% | 116B | |
| +0.88% | +1.88% | +1.66% | +35.46% | 115B | |
| -2.26% | +18.07% | -43.85% | +5.76% | 93.1B | |
| -0.31% | -4.72% | -3.36% | +74.94% | 62.09B | |
| +0.17% | +1.64% | +8.50% | +82.24% | 55.87B | |
| +0.07% | +0.42% | +5.94% | -22.27% | 53.12B | |
| +0.30% | +1.70% | -11.26% | +42.01% | 44.22B | |
| +0.10% | +3.37% | -4.73% | -8.71% | 33.59B | |
| Average | -0.10% | +0.47% | -7.62% | +23.69% | 75.37B | |
| Weighted average by Cap. | +0.17% | -0.15% | -12.65% | +23.77% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 3,194B 20.19B 18.11B 16.74B 15.17B 28.33B 1,923B 28.67B 200B 79.74B 1,006B 75.75B 74.15B | 3,289B 20.79B 18.65B 17.24B 15.62B 29.17B 1,980B 29.53B 206B 82.11B 1,036B 78B 76.36B |
| Net income | 23.41B 148M 133M 123M 111M 208M 14.09B 210M 1.47B 585M 7.38B 555M 544M | 27.15B 172M 154M 142M 129M 241M 16.34B 244M 1.7B 678M 8.55B 644M 630M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/10/26 | ¥2,415.00 | -1.75% | 487,000 |
| 27/10/26 | ¥2,458.00 | -0.63% | 376,500 |
| 26/10/26 | ¥2,473.50 | +2.78% | 420,500 |
| 23/10/26 | ¥2,406.50 | +1.45% | 497,700 |
| 22/10/26 | ¥2,372.00 | +0.89% | 471,100 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 2784 Stock
Select your edition
All financial news and data tailored to specific country editions
